Eli Lilly has confirmed an additional $4.5 billion for its Lebanon, Indiana campus — bringing total Indiana capital commitments since 2020 to more than $21 billion — and the procurement window for the 2027 API site opening is already running. If your operation is anywhere in the central Indiana corridor, this is not background noise. This is a direct demand signal on your workforce, your utility infrastructure, and your supply chain positioning.

Watch this TEG Daily on YouTube

Eli Lilly Lebanon Indiana: Three Facilities, One County

On May 6th, Lilly opened Lilly Lebanon Advanced Therapies — its first dedicated genetic medicine manufacturing facility anywhere in the world. That same day, it confirmed the additional $4.5 billion spread across two of its three Lebanon campus sites.

The second facility, Lebanon API, is on track for a 2027 opening. CEO David Ricks did not frame this as aspirational. He said that when Lebanon API opens, it will be the largest active pharmaceutical ingredient production site in U.S. history. A third facility, the Lilly Medicine Foundry, has been announced with a timeline still developing.

Three facilities. One campus. One county. Each with distinct production purposes and distinct supplier, maintenance, and infrastructure requirements.

Why the 2027 API Opening Is the Near-Term Indicator to Watch

The Lebanon API site will produce tirzepatide injectables — already the most prescribed injectable medications for weight management and type 2 diabetes in the country — along with Lilly's first FDA-approved oral weight loss pill and a late-stage obesity and cardiometabolic drug currently in development.

Procurement qualification timelines for a facility of this scale typically run 12 to 18 months minimum. The 2027 opening is less than two years away. For Indiana manufacturers in packaging, precision components, industrial services, skilled trades, or specialized maintenance, that timeline is not abstract. The window is open now, and it will not stay open indefinitely.

What a Build-Out of This Scale Does to the Regional Environment

A campus drawing $21 billion in capital since 2020 does not operate in isolation. It draws on every shared resource in the region: workforce pools, skilled trades, utility capacity, road and logistics infrastructure.

According to an Indiana University Kelley School of Business analysis, every Lilly job supports more than two additional jobs statewide, and every dollar Lilly spends locally generates up to $4 in regional economic activity. That multiplier is real — but only for operators who are positioned to capture it. If your capabilities are a fit and you are not actively pursuing qualification, that spending flows to out-of-state vendors instead.

The workforce picture has the same dual character. The Kelly School data is a net positive for the regional economic base. It also means the pool of skilled engineers, technicians, and manufacturing operators in central Indiana is being drawn toward a well-capitalized employer with long-term commitments and high-complexity work. If you are already competing for that talent in Boone County or the surrounding corridor, that competition intensifies as Lebanon campus ramps toward full operation.

On utilities: pharmaceutical manufacturing at commercial scale — genetic medicine production, API synthesis — carries enormous utility load. Power, water, industrial gases, wastewater treatment. As Lilly Lebanon API moves toward its 2027 opening, utility load in Boone County will increase substantially. If your facility is on the same grid infrastructure, that is worth monitoring now, not after it shows up in your bills.

Questions for Your Morning Huddle

Q: Where does our operation sit in the Lilly Lebanon supply chain, and are we actively pursuing qualification as a vendor, contractor, or service provider for that campus? A: Procurement qualification for a facility of this scale typically runs 12 to 18 months minimum. The 2027 API site opening is less than two years away — if you have not started the qualification process, you are already behind the curve.

Q: Are we tracking workforce and infrastructure developments in Boone County closely enough to anticipate how they'll affect our hiring, utility costs, and logistics over the next two to three years? A: The Lilly build-out intensifies competition for skilled trades and engineers across the central Indiana corridor and will drive substantial utility load increases in Boone County. Operators in that region should be monitoring both hiring pipelines and grid capacity developments now, not after impacts show up in bills and recruiting timelines.

Q: Does Lilly Lebanon Advanced Therapies' manufacturing complexity create talent recruitment competition for the specialized engineers and technicians our facility depends on? A: Lilly's genetic medicine facility deploys entirely new manufacturing processes at commercial scale for the first time — with no established commercial precedent. Once those processes are qualified and running, Lilly is not moving them. That creates durable, long-term competition for the same engineers and technicians many Indiana manufacturers depend on.

Watch this TEG Daily on YouTube

‍